Global bioprosthetic heart valves Market Size To Reach $25.1 Billion By 2035

Global bioprosthetic heart valves market is projected to grow from $9.5 billion in 2025 and is projected to reach $25.1 billion by 2035, growing at a CAGR of 10.2% during the forecast period 2026-2035. The global bioprosthetic heart valves market is evolving with a growing preference for less invasive treatment approaches and improved clinical outcomes. Advancements in transcatheter technologies have expanded treatment options for patients who were previously considered unsuitable for surgery. The shift toward minimally invasive procedures is being supported by ongoing refinements in valve design, imaging guidance, and delivery systems. In parallel, increasing awareness of valvular heart diseases and earlier diagnosis are contributing to higher procedural volumes. The aging population, which is more prone to degenerative valve conditions, continues to influence demand patterns across healthcare systems. Additionally, improvements in post-procedural care and follow-up practices are supporting wider adoption in routine clinical settings.

Browse the full report description of “Bioprosthetic Heart Valves Market Size, Share & Trends Analysis by Product Type (Transcatheter Bioprosthetic Valves, Surgical Bioprosthetic Valves (Stented and Stentless), and Sutureless Bioprosthetic Valves), by Valve Position (Aortic Valve, Mitral Valve, Tricuspid Valve, and Pulmonary Valve), by Material Type (Bovine Tissue, Porcine Tissue, and Others), and by End Users (Hospitals, Cardiac Surgery Centers, Specialty Cardiac Clinics, and Ambulatory Surgical Centers Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/bioprosthetic-heart-valves-market

Another notable trend is the continuous development of biomaterials aimed at enhancing durability and reducing complications associated with tissue valves. Manufacturers are focusing on advanced tissue processing techniques to address issues such as calcification and structural deterioration over time. There is also a gradual expansion of indications beyond traditional high-risk patients to include broader patient groups, supported by evolving clinical evidence. Healthcare providers are increasingly integrating these devices into treatment protocols as experience and confidence grow. At the same time, regulatory progress in various regions is facilitating the introduction of newer valve technologies. Collectively, these factors are shaping a steady progression of the market within the global cardiovascular device landscape.

Competitive Landscape of the Bioprosthetic Heart Valves Market

The key players in the bioprosthetic heart valves market are Edwards Lifesciences Corp., Medtronic plc, Abbott Laboratories, Boston Scientific Corp., and LivaNova PLC, among others. The competitive landscape is characterized by a concentrated group of multinational medical device companies with strong capabilities in structural heart technologies. These organizations maintain their positions through continuous product development, clinical research, and regulatory approvals across key markets. Their portfolios span both transcatheter and surgical solutions, enabling broad clinical adoption. Ongoing investments in innovation and geographic expansion further support their presence in this segment.

• In September 2025, Edwards Lifesciences launched a next-generation transcatheter heart valve platform in India, designed to improve durability and reduce complications such as calcification and paravalvular leak. The product incorporates advanced tissue technology and supports long-term valve performance, addressing key limitations of earlier bioprosthetic valves. This launch highlights geographic expansion and the adaptation of advanced valve technologies into emerging markets.

• In January 2025, Abbott introduced the Navitor Vision transcatheter heart valve system in India, targeting patients with severe aortic stenosis who are at high surgical risk. The product enhances visualization and placement accuracy, supporting improved procedural outcomes. This launch reflects Abbott’s ongoing expansion within the transcatheter bioprosthetic valve segment and its focus on emerging market penetration.

• In January 2024, Medtronic received FDA approval and subsequently launched the Avalus Ultra surgical bioprosthetic valve, engineered to improve ease of implantation and long-term patient management. The valve builds on Medtronic’s surgical portfolio, indicating continued innovation alongside transcatheter solutions. This reflects sustained investment in surgical bioprosthetic valves despite the rapid growth of minimally invasive procedures.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Valve Position
  • By Material Type
  • By End Users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Edwards Lifesciences Corp., Medtronic plc, Abbott Laboratories, Boston Scientific Corp., and LivaNova PLC.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Bioprosthetic Heart Valves Market Report Segment

By Product Type

• Transcatheter Bioprosthetic Valves (TAVR/TAVI)
• Surgical Bioprosthetic Valves
  • Stented
  • Stentless
• Sutureless Bioprosthetic Valves

By Valve Position

• Aortic Valve
• Mitral Valve
• Tricuspid Valve
• Pulmonary Valve

By Material Type

• Bovine Tissue
• Porcine Tissue
• Others

By End Users

• Hospitals
• Cardiac Surgery Centers
• Specialty Cardiac Clinics
• Ambulatory Surgical Centers

Global Bioprosthetic Heart Valves Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bioprosthetic-heart-valves-market